Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
European Heart Journal. Cardiovascular Imaging|August 22, 2024
Contemporary treatment options in heart failure with preserved ejection fractionAlexander Peikert, Scott D Solomon
European Heart Journal|September 2, 2025
Left ventricular hypertrophy and myocardial fibrosis in heart failure with preserved ejection fraction: mechanisms and treatmentAlexander Peikert, Marianna Fontana, Scott D Solomon, et al.
Circulation. Heart Failure|February 2, 2026
Cellular Interactions and Immunometabolic Mechanisms in Heart Failure With Preserved Ejection Fraction: From Molecular Mechanisms to Clinical EvidenceAlexander Peikert, Antonio Vacca, Giuseppe D Norata, et al.
Journal of the American College of Cardiology|March 11, 2026
Designing Next-Generation Cardiometabolic Outcome Trials for Obesity MedicinesElke Platz, Alexander Peikert, Biykem Bozkurt, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 28, 2021
Coronary artery bypass grafting versus stent implantation in patients with chronic coronary syndrome and left main disease: insights from a register throughout GermanyPeter Stachon, Klaus Kaier, Philip Hehn, et al.
Medicine|September 24, 2021
Outcomes of female and male patients suffering from coronary artery disease: A nation-wide registry of patients admitted as emergencyMarkus Jäckel, Klaus Kaier, Jonathan Rilinger, et al.
Global Heart|February 10, 2022
Use and Outcomes of Acute Treatment Strategies in Patients with Severe Aortic Valve StenosisSven M Piepenburg, Klaus Kaier, Christoph B Olivier, et al.
European Journal of Heart Failure|July 27, 2022
Longitudinal trajectories in renal function before and after heart failure hospitalization among patients with heart failure with preserved ejection fraction in the PARAGON-HF trialSafia Chatur, Muthiah Vaduganathan, Alexander Peikert, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 21, 2019
Residual inflammatory risk in coronary heart disease: incidence of elevated high-sensitive CRP in a real-world cohortAlexander Peikert, Klaus Kaier, Julian Merz, et al.
European Journal of Heart Failure|February 4, 2022
Effects of sacubitril/valsartan versus valsartan on renal function in patients with and without diabetes and heart failure with preserved ejection fraction: insights from PARAGON-HFAlexander Peikert, Muthiah Vaduganathan, Finnian Mc Causland, et al.
Pageof 3